PubMed (OMIM) for id: 4205

Year	Number of Results
1991	1
1992	1
1993	1
1994	1
1995	2
1996	1
1999	1
2000	2
2002	1
2003	2
2004	2
2005	2
2006	4
2007	1
2008	1
2010	1
2013	1
2024	0

1

MEF2 is an in vivo immune-metabolic switch.

Clark RI, Tan SW, Péan CB, Roostalu U, Vivancos V, Bronda K, Pilátová M, Fu J, Walker DW, Berdeaux R, Geissmann F, Dionne MS. Clark RI, et al. Cell. 2013 Oct 10;155(2):435-47. doi: 10.1016/j.cell.2013.09.007. Epub 2013 Sep 26. Cell. 2013. PMID: 24075010 Free PMC article.

2

Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.

Pfeiffer BE, Zang T, Wilkerson JR, Taniguchi M, Maksimova MA, Smith LN, Cowan CW, Huber KM. Pfeiffer BE, et al. Neuron. 2010 Apr 29;66(2):191-7. doi: 10.1016/j.neuron.2010.03.017. Neuron. 2010. PMID: 20434996 Free PMC article.

3

Cocaine regulates MEF2 to control synaptic and behavioral plasticity.

Pulipparacharuvil S, Renthal W, Hale CF, Taniguchi M, Xiao G, Kumar A, Russo SJ, Sikder D, Dewey CM, Davis MM, Greengard P, Nairn AC, Nestler EJ, Cowan CW. Pulipparacharuvil S, et al. Neuron. 2008 Aug 28;59(4):621-33. doi: 10.1016/j.neuron.2008.06.020. Neuron. 2008. PMID: 18760698 Free PMC article.

4

An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.

Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN. Liu N, et al. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20844-9. doi: 10.1073/pnas.0710558105. Epub 2007 Dec 19. Proc Natl Acad Sci U S A. 2007. PMID: 18093911 Free PMC article.

5

A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.

Shalizi A, Gaudillière B, Yuan Z, Stegmüller J, Shirogane T, Ge Q, Tan Y, Schulman B, Harper JW, Bonni A. Shalizi A, et al. Science. 2006 Feb 17;311(5763):1012-7. doi: 10.1126/science.1122513. Science. 2006. PMID: 16484498

6

Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number.

Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME. Flavell SW, et al. Science. 2006 Feb 17;311(5763):1008-12. doi: 10.1126/science.1122511. Science. 2006. PMID: 16484497

7

Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.

Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD. Xu J, et al. J Biol Chem. 2006 Apr 7;281(14):9152-62. doi: 10.1074/jbc.M510217200. Epub 2006 Feb 9. J Biol Chem. 2006. PMID: 16469744 Free article.

8

The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.

González P, García-Castro M, Reguero JR, Batalla A, Ordóñez AG, Palop RL, Lozano I, Montes M, Alvarez V, Coto E. González P, et al. J Med Genet. 2006 Feb;43(2):167-9. doi: 10.1136/jmg.2005.035071. Epub 2005 Jun 15. J Med Genet. 2006. PMID: 15958500 Free PMC article.

9

Lack of MEF2A mutations in coronary artery disease.

Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, Hébert S, Cohen JC, McPherson R, Pennacchio LA. Weng L, et al. J Clin Invest. 2005 Apr;115(4):1016-20. doi: 10.1172/JCI24186. J Clin Invest. 2005. PMID: 15841183 Free PMC article.

10

Transcription factor MEF2A mutations in patients with coronary artery disease.

Bhagavatula MR, Fan C, Shen GQ, Cassano J, Plow EF, Topol EJ, Wang Q. Bhagavatula MR, et al. Hum Mol Genet. 2004 Dec 15;13(24):3181-8. doi: 10.1093/hmg/ddh329. Epub 2004 Oct 20. Hum Mol Genet. 2004. PMID: 15496429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year